Improving/VBG the/DT throughput/NN of/IN molecular/JJ docking/NN ,/, a/DT computationally/RB intensive/JJ phase/NN of/IN the/DT virtual/JJ screening/NN process/NN ,/, is/VBZ a/DT highly/RB sought/VBN area/NN of/IN research/NN since/IN it/PRP has/VBZ a/DT significant/JJ weight/NN in/IN the/DT drug/NN designing/VBG process/NN ./.
With/IN such/JJ improvements/NNS ,/, the/DT world/NN might/MD find/VB cures/NNS for/IN incurable/JJ diseases/NNS like/IN HIV/NNP disease/NN and/CC Cancer/NN sooner/RBR ./.
Our/PRP$ approach/NN presented/VBN in/IN this/DT paper/NN is/VBZ to/TO utilize/VB a/DT multi-core/JJ environment/NN to/TO introduce/VB Data/NNP Level/NNP Parallelism/NN (/-LRB- DLP/NN )/-RRB- to/IN the/DT Autodock/NNP Vina/NNP software/NN ,/, which/WDT is/VBZ a/DT widely/RB used/VBN for/IN molecular/JJ docking/NN software/NN ./.
Autodock/NNP Vina/NNP already/RB exploits/VBZ Instruction/NN Level/NN Parallelism/NN (/-LRB- ILP/NN )/-RRB- in/IN multi-core/JJ environments/NNS and/CC therefore/RB optimized/VBN for/IN such/JJ environments/NNS ./.
However/RB ,/, with/IN the/DT results/NNS we/PRP have/VBP obtained/VBN ,/, it/PRP can/MD be/VB clearly/RB seen/VBN that/IN our/PRP$ approach/NN has/VBZ enhanced/VBN the/DT throughput/NN of/IN the/DT already/RB optimized/VBN software/NN by/IN more/JJR than/IN six/CD times/NNS ./.
This/DT will/MD dramatically/RB reduce/VB the/DT time/NN consumed/VBN for/IN the/DT lead/NN identification/NN phase/NN in/IN drug/NN designing/VBG along/IN with/IN the/DT shift/NN in/IN the/DT processor/NN technology/NN from/IN multi-core/JJ to/IN many/JJ -/HYPH core/NN of/IN the/DT current/JJ era/NN ./.
Therefore/RB ,/, we/PRP believe/VBP that/IN the/DT contribution/NN of/IN this/DT project/NN will/MD effectively/RB make/VB it/PRP possible/JJ to/TO expand/VB the/DT number/NN of/IN small/JJ molecules/NNS docked/VBN against/IN a/DT drug/NN target/NN and/CC improving/VBG the/DT chances/NNS to/TO design/VB drugs/NNS for/IN incurable/JJ diseases/NNS ./.
